Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. COVID-19 and first manic episodes: a systematic review.Psychiatry research · 2022
   Pooled it
2. COVCOG: Immediate and long-term cognitive improvement after cognitive versus emotion management psychoeducation programs - a randomized trial in covid patients with neuropsychological difficulties.BMC neurology · 2023
   Trial
3. A rare clinical presentation after COVID-19: Manic episode with psychotic features.Psychiatry research case reports · 2023
   Article
4. COVID-19 neuropsychiatric repercussions: Current evidence on the subject.World journal of methodology · 2022
   Review
5. New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus.Schizophrenia research · 2022
   Article
6. Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution.Frontiers in psychiatry · 2022
   Article
7. Cognitive and Neuropsychiatric Features of COVID-19 Patients After Hospital Dismission: An Italian Sample.Frontiers in psychology · 2022
   Article
8. Psychotic Agitation in a Patient with COVID-19: Pathogenesis or Iatrogenesis?Psychiatry and clinical psychopharmacology · 2021
   Article
9. COVID-19-related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2021
   Article
10. SARS-CoV-2-associated first episode of acute mania with psychotic features.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2021
    Article
11. Nutritional Interventions for COVID-19: A Role for Carnosine?Nutrients · 2021
    Article
12. Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2021
    Review
13. Reissuing the sigma receptors for SARS-CoV-2.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2020
    Article
14. May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Article
15. Participation of Endosomes in Toll-Like Receptor 3 Transportation Pathway in Murine Astrocytes.Frontiers in cellular neuroscience · 2020
    Article
16. Prolonged Neuropsychological Deficits, Central Nervous System Involvement, and Brain Stem Affection After COVID-19-A Case Series.Frontiers in neurology · 2020
    Article
17. Modeling SARS-CoV-2 infection in individuals with opioid use disorder with brain organoids.Journal of tissue engineering
    Review

Corrections and comments

• Comment on
  Guillain Barre syndrome associated with COVID-19 infection: A case report.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as